Cargando…

Title: Severe Extra Pyramidal symptoms vs Neuroleptic Malignant Syndrome following long acting depot formulation of typical antipsychotic- a diagnostic dilemma and its management: a case report.

BACKGROUND: Flupenthixol Decanoate is a long acting typical antipsychotic which mainly acts as an antagonist of central D2 receptors but the chances of both EPS and NMS are high with its use.In this case report we are going to discuss how challenging it might be sometimes to differentiate between se...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Abstract- Poster
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129775/ http://dx.doi.org/10.4103/0019-5545.341946

Ejemplares similares

Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
por: Fekadu, Abebaw, et al.
Publicado: (2005)

Typical Neuroleptic Malignant Syndrome Presented in Patient on Maintenance Quetiapine
por: Raval, Chintan Madhusudan, et al.
Publicado: (2014)

Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
por: Korchia, Théo, et al.
Publicado: (2018)

Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment
por: Sahoo, Manoj Kumar, et al.
Publicado: (2014)

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription
por: Reilly, Thomas J, et al.
Publicado: (2017)

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
por: Hirjak, Dusan, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics
por: Ramadas, Smitha, et al.
Publicado: (2022)

The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome
por: Kyotani, Yoji, et al.
Publicado: (2023)

Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal
por: Maeda, Keisuke, et al.
Publicado: (2023)

An Unusual Case of Neuroleptic Malignant Syndrome on a Stable Dose of Antipsychotic
por: Sanger, Emily, et al.
Publicado: (2023)

Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma
por: Paul, Gunchan, et al.
Publicado: (2016)

Amyloid as a Depot for the Formulation of Long-Acting Drugs
por: Maji, Samir K, et al.
Publicado: (2008)

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients
por: Ascher-Svanum, Haya, et al.
Publicado: (2009)

A Case of Catatonia and Neuroleptic Malignant Syndrome Probably Associated with Antipsychotic in Korea
por: Choi, Ho-Dong, et al.
Publicado: (2011)

Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics
por: Feng, Yuhui, et al.
Publicado: (2013)

Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene
por: Ngo, Vivian, et al.
Publicado: (2019)

Enteric Fever: Diagnostic Dilemma Encountered in Domperidone-Induced Neuroleptic Malignant Syndrome
por: Akhunzada, Hawwa A, et al.
Publicado: (2021)

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
por: Belvederi Murri, Martino, et al.
Publicado: (2015)

Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent
por: Park, Jong-Il, et al.
Publicado: (2019)

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
por: Sarkar, Siddharth, et al.
Publicado: (2017)

Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system
por: Hirofuji, Sakiko, et al.
Publicado: (2023)

Resolution of symptoms in neuroleptic malignant syndrome
por: Pereira, Yvonne D.S., et al.
Publicado: (2010)

Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study
por: Ahmadkhaniha, Hamid-Reza, et al.
Publicado: (2014)

The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics
por: Möller, Hans-Jurgen
Publicado: (2010)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)

Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient
por: Espiridion, Eduardo D, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman
por: Burad, Jyoti, et al.
Publicado: (2021)

A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome
por: Hara, Yoshiki, et al.
Publicado: (2016)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

Physical health monitoring in antipsychotic depot clinic
por: Davies, Rebecca, et al.
Publicado: (2021)

Metabolic Syndrome Monitoring in Patients on Depot Antipsychotics
por: Ateem, Salah
Publicado: (2023)

Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India
por: Raghavan, Vijaya, et al.
Publicado: (2020)

Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neuroleptics
por: Carr, Chelsea N., et al.
Publicado: (2016)

Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
por: Barbui, Corrado, et al.
Publicado: (2020)

Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report
por: Langan, Julie, et al.
Publicado: (2012)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iqls4jd0n8a0ago78mglnl80oq